Ginkgo Bioworks announces appointment of Steven P. Coen as Chief Accounting Officer

Coen brings over 30 years of public accounting and corporate finance leadership experience

Ginkgo Bioworks Holdings announced the appointment of Steven P. Coen, CPA, a seasoned finance executive with more than 30 years of public accounting and corporate finance leadership experience, as Chief Accounting Officer (CAO), effective May 15, 2023. Most recently, Coen was the Corporate Vice President and Corporate Controller for Charles River Laboratories, a publicly held global contract research organization for pharmaceutical and biotechnology companies, governmental agencies and leading academic institutions, with approximately 20,000 employees across 150 locations in over 20 countries and annual revenues of approximately $4.0 billion. Prior to that, Coen served in accounting and finance leadership roles in the technology and medical device industries after spending more than 17 years in the audit practice at Deloitte & Touche LLP.

Marie E. Fallon, Ginkgo’s current CAO, will step down from her role effective May 15, 2023. Fallon was instrumental in preparing Ginkgo to go public and led Ginkgo through its first two annual reporting cycles. Fallon’s resignation was a personal decision to pursue other opportunities and is not the result of any disagreement with the Company. Fallon will remain with the Company through June 2, 2023, to support a smooth transition of responsibilities and will then serve as a consultant to Ginkgo for an interim period.

Coen brings over 30 years of public